KAITLYNN EARLS: Open Payments
NPI 1710459706 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$77,583 in 260 payments from 14 companies in 2025. Trend: 2023 $62,889 · 2024 $80,134 · 2025 $77,583
Speaker / faculty: $60,076Travel & lodging: $7,915Consulting: $5,925Food & beverage: $3,529Education: $138
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 57 | $35,051 |
| Janssen Pharmaceuticals, Inc | 37 | $19,945 |
| Otsuka America Pharmaceutical, Inc. | 51 | $15,364 |
| ABBVIE INC. | 45 | $6,119 |
| Supernus Pharmaceuticals, Inc. | 14 | $249 |
| Teva Pharmaceuticals USA, Inc. | 14 | $247 |
| Vanda Pharmaceuticals Inc. | 15 | $173 |
| Lundbeck LLC | 12 | $149 |
| Collegium Pharmaceutical, Inc. | 4 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
Products named: INGREZZA, INVEGA SUSTENNA, ABILIFY MAINTENA, VRAYLAR, ABILIFY ASIMTUFII, Qelbree, REXULTI, HETLIOZ.
Industry payments across TN — which companies pay providers there.
